Oscar Health Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Mark Bertolini
Algemeen directeur
US$44.5m
Totale compensatie
| Percentage CEO-salaris | 1.0% |
| Dienstverband CEO | 1.6yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 3.4yrs |
| Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%
Oct 29
Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet
Sep 13Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback
Sep 03Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain
Jul 02Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump
May 03Oscar Health: Strong Industry Catalyst With Margin Expansion Potential
Apr 13This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts
Feb 12Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Oscar Health: Flexible Business Model Is Paying Off
Jan 30Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce
Jan 19Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward
Nov 21Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024
Nov 15Oscar Health: Decreasing Memberships Is Worrying
Sep 22Oscar Health Shares Quadrupled, But They Are Still Cheap
Jul 03Oscar Health: High Growth And Improving Profitability Make It A Buy
Jun 15Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M
Feb 09Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable
Jan 18Oscar Health Is Back On Track
Nov 11Oscar Health: Improving Risk/Reward Profile To Watch
Oct 03Florida health insurer terminating agreement with Oscar Health
Aug 30Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$29m |
| Jun 30 2024 | n/a | n/a | US$18m |
| Mar 31 2024 | n/a | n/a | -US$54m |
| Dec 31 2023 | US$45m | US$450k | -US$271m |
Compensatie versus markt: De totale vergoeding ($USD 44.54M ) Mark } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.56M ).
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Mark te vergelijken met de prestaties van het bedrijf.
CEO
Mark Bertolini (67 yo)
1.6yrs
Tenure
US$44,540,814
Compensatie
Mr. Mark Thomas Bertolini serves as CEO & Director of Oscar Health, Inc. (formerly known as Mulberry Health Inc.). He is an Advisor at Wisdom Ventures Fund, LLC. He was Co-Chief Executive Officer of Bridge...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 1.6yrs | US$44.54m | geen gegevens | |
| Co-Founder | 12.1yrs | US$854.00k | 1.49% $ 58.9m | |
| Chief Financial Officer | 1.3yrs | US$6.20m | 0.35% $ 13.6m | |
| Chief Legal Officer | 2.8yrs | US$3.19m | 0.089% $ 3.5m | |
| Executive VP & Chief Insurance Officer | no data | US$5.75m | 0.19% $ 7.5m | |
| Co-Founder & Vice Chairman | 3.8yrs | geen gegevens | geen gegevens | |
| Chief Operating Officer | no data | geen gegevens | 0.034% $ 1.3m | |
| Chief Accounting Officer | 3.3yrs | geen gegevens | 0.055% $ 2.2m | |
| Vice President of Treasury & Investor Relations | no data | geen gegevens | geen gegevens | |
| Chief People Officer | no data | geen gegevens | geen gegevens | |
| Senior Advisor | 8.8yrs | US$1.09m | geen gegevens | |
| President of Oscar Medical Group | 3.6yrs | geen gegevens | geen gegevens |
3.4yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van OSCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 1.6yrs | US$44.54m | geen gegevens | |
| Co-Founder | 11.9yrs | US$854.00k | 1.49% $ 58.9m | |
| Co-Founder & Vice Chairman | 3.8yrs | geen gegevens | geen gegevens | |
| Independent Chairman | 3.8yrs | US$299.98k | 0.25% $ 10.0m | |
| Independent Director | 1.9yrs | US$264.99k | geen gegevens | |
| Independent Director | 3.8yrs | US$277.49k | 0.043% $ 1.7m | |
| Director | 3.8yrs | geen gegevens | 0.32% $ 12.7m | |
| Independent Director | 1.9yrs | US$249.99k | 0.021% $ 819.3k | |
| Independent Director | 3.8yrs | US$259.96k | 0.020% $ 799.1k | |
| Independent Director | 3.8yrs | US$259.99k | 0.020% $ 799.1k |
3.8yrs
Gemiddelde duur
51.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van OSCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).